FBLG vs GRMN · $24.0M cap vs P/E 28, rev $7.25B
FibroBiologics, Inc. Common Stock (FBLG) versus Garmin Ltd (GRMN) — a side-by-side from cached financials, not a winner call.
FibroBiologics, Inc. Common Stock (FBLG) is a biotechnology company listed on US.
Garmin Ltd (GRMN) is a scientific & technical instruments company listed on US.
FBLG does not have a complete income-statement cache yet.
Latest reported GRMN revenue for 2025-12-27 was $7.25B. Net income was $1.66B. Revenue was up 15.1% from 2024-12-28 to 2025-12-27. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
FBLG currently screens at market cap $24.0M. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
Not investment advice. Open the FBLG and GRMN stock pages for the full models.
Not investment advice.